Literature DB >> 24210773

Effectiveness of CT-guided sclerotherapy with estimated ethanol concentration for treatment of symptomatic simple hepatic cysts.

Jin Hong Yu1, Yong Du2, Yang Li3, Han Feng Yang4, Xiao Xue Xu5, Hou Jun Zheng6, Bing Li7.   

Abstract

BACKGROUND AND
OBJECTIVE: The mean Hounsfield value of 99.9% ethanol did get down to -190 Hounsfield units (HU), there was a linear correlation between ethanol concentration and Hounsfield values. We aimed to evaluate whether sclerotherapy with estimated ethanol concentration was helpful in improving the success rate for treatment of symptomatic simple hepatic cysts.
METHODS: Forty-five patients with 52 symptomatic simple hepatic cysts were enrolled in this study. Twenty-one patients (24 cysts, group A) were treated by sclerotherapy without estimated ethanol concentration and 24 patients (28 cysts, group B) with estimated ethanol concentration. The Chi-square test and Mann-Whitney U test were used to compare the difference in characteristics and treatment outcomes of the subjects between these two groups.
RESULTS: The mean cyst size before and after treatment were 8.4cm and 2.3cm, respectively, in group A, and 8.2cm and 0.8cm, respectively, in group B. There was no significant difference in the initial size of hepatic cysts between the groups. However, the final size was significantly smaller in group B (P=0.022). The mean ethanol exposure time was 18.3minutes in group B, which was less than that in group A (P<0.001). The success rate was significantly higher in group B (96.4%) than in group A (70.8%) (P=0.03). There were no major complications in either group.
CONCLUSION: CT-guided sclerotherapy with estimated ethanol concentration yields better results than those without estimated ethanol concentration in the treatment of symptomatic simple hepatic cysts.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210773     DOI: 10.1016/j.clinre.2013.09.008

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  6 in total

1.  Fatal intrahepatic hemorrhage after nadroparin use for total hip arthroplasty.

Authors:  Francesco Ventura; Alessandro Bonsignore; Francesco De Stefano; Enrico Pizzorno; Cristian Palmiere
Journal:  Forensic Sci Med Pathol       Date:  2014-08-10       Impact factor: 2.007

2.  Single-session alcohol sclerotherapy of symptomatic liver cysts using 10-20 min of ethanol exposure: no recurrence at 2-16 years of follow-up.

Authors:  Trond Bjerke Larssen; Asgaut Viste; Arild Horn; Ingfrid Salvesen Haldorsen; Ansgar Espeland
Journal:  Abdom Radiol (NY)       Date:  2016-09

Review 3.  Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management.

Authors:  Marianna G Mavilia; Tina Pakala; Marco Molina; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2018-01-05

4.  Percutaneous aspiration and sclerotherapy of a giant simple hepatic cyst causing obstructive jaundice: A case report and review of literature.

Authors:  Xu-Xia He; Mei-Xing Sun; Ke Lv; Jian Cao; Sheng-Yu Zhang; Jing-Nan Li
Journal:  World J Gastrointest Surg       Date:  2022-07-27

5.  Comparison of the Efficacy and Safety of Single-Session OK-432 and Multiple-Session 99% Ethanol Sclerotherapy for Symptomatic Simple Hepatic Cysts.

Authors:  Zhiqiang Mo; Fangfang Yang; Ling Lv; Jian He; Qin Gou; Xiaoming Chen; Wenhang Zhuang; Qicong Mai
Journal:  Front Med (Lausanne)       Date:  2022-07-15

6.  Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.

Authors:  Titus F M Wijnands; Maxime Ronot; Tom J G Gevers; Julie Benzimra; Leo J Schultze Kool; Valérie Vilgrain; Joost P H Drenth
Journal:  Eur Radiol       Date:  2016-05-14       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.